| Eyegate Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing products for treating disorders of the eye. Co.'s key product in clinical development is the EyeGate Ocular Bandage Gel, a topically applied eye drop formulation of modified hyaluronic acid (HA). HA is a naturally occurring polymer that is used in various physiological processes, including wound healing, hydration, tissue homeostasis, and joint lubrication. Co. modifies the HA through chemical cross-linking, which allows it to adhere to the ocular surface providing protection and lubrication for the treatment of corneal wounds, defects, and epitheliopathies. We show 26 historical shares outstanding datapoints in our EYEG shares outstanding history coverage, used to compute EYEG market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing EYEG market cap history over the course of time is important for investors
interested in comparing EYEG's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of EYEG versus a peer is one thing; comparing
EYEG market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like EYEG can fluctuate over the course of history.
With this page we aim to empower investors researching EYEG by allowing them to research the EYEG market cap history.